This company listing is no longer active
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Biohaven Pharmaceutical Holding マネジメント
マネジメント 基準チェック /24
主要情報
Vlad Coric
最高経営責任者
US$10.9m
報酬総額
| CEO給与比率 | 6.9% |
| CEO在任期間 | 7yrs |
| CEOの所有権 | 1.3% |
| 経営陣の平均在職期間 | 3.5yrs |
| 取締役会の平均在任期間 | 4yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$1b |
| Mar 31 2022 | n/a | n/a | -US$791m |
| Dec 31 2021 | US$11m | US$750k | -US$847m |
| Sep 30 2021 | n/a | n/a | -US$865m |
| Jun 30 2021 | n/a | n/a | -US$889m |
| Mar 31 2021 | n/a | n/a | -US$859m |
| Dec 31 2020 | US$1m | US$622k | -US$767m |
| Sep 30 2020 | n/a | n/a | -US$698m |
| Jun 30 2020 | n/a | n/a | -US$609m |
| Mar 31 2020 | n/a | n/a | -US$639m |
| Dec 31 2019 | US$7m | US$550k | -US$529m |
| Sep 30 2019 | n/a | n/a | -US$434m |
| Jun 30 2019 | n/a | n/a | -US$390m |
| Mar 31 2019 | n/a | n/a | -US$218m |
| Dec 31 2018 | US$5m | US$500k | -US$241m |
| Sep 30 2018 | n/a | n/a | -US$213m |
| Jun 30 2018 | n/a | n/a | -US$195m |
| Mar 31 2018 | n/a | n/a | -US$202m |
| Dec 31 2017 | US$4m | US$421k | -US$139m |
| Sep 30 2017 | n/a | n/a | -US$138m |
| Jun 30 2017 | n/a | n/a | -US$123m |
| Mar 31 2017 | n/a | n/a | -US$83m |
| Dec 31 2016 | US$784k | US$350k | -US$64m |
報酬と市場: Vlad's total compensation ($USD10.92M) is above average for companies of similar size in the German market ($USD5.34M).
報酬と収益: Vlad's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Vlad Coric (51 yo)
7yrs
在職期間
US$10,924,824
報酬
Dr. Vladimir Coric, also known as Vlad, M.D., is Director at Pyramid Biosciences Inc. since August 2020. He has been Independent Director of Social Capital Suvretta Holdings Corp. I since June 29, 2021. He...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of the Board | 7yrs | US$10.92m | 1.29% $ 141.8m | |
| Chief Financial Officer | less than a year | US$6.03m | 0.0086% $ 949.2k | |
| Senior Vice President of Clinical Operations | 5.8yrs | US$3.76m | 0.016% $ 1.8m | |
| Chief Medical Officer | 5.3yrs | US$3.88m | 0.023% $ 2.5m | |
| Chief Commercial Officer of Migraine & Common Diseases | 3.5yrs | US$4.69m | 0.020% $ 2.2m | |
| Director of Accounting | 3.8yrs | データなし | データなし | |
| VP & Chief Accounting Officer | 1.2yrs | データなし | 0.0057% $ 625.1k | |
| Chief Scientific Officer | 5.8yrs | US$2.79m | 0% $ 0 | |
| Executive Administrative Assistant | no data | データなし | データなし | |
| President & GM of Biohaven Ireland and Chief Compliance Officer | 1.4yrs | データなし | データなし | |
| General Counsel & Chief Legal Officer | less than a year | データなし | データなし | |
| Manager of Medical Information & Communication | 2.8yrs | データなし | データなし |
3.5yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: 2VN's management team is considered experienced (3.5 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of the Board | 7yrs | US$10.92m | 1.29% $ 141.8m | |
| Corporate Secretary & Director | less than a year | データなし | データなし | |
| Independent Director | 8.8yrs | US$560.01k | 4.25% $ 466.4m | |
| Independent Director | 5.2yrs | US$560.06k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$990.02k | 0.0041% $ 446.0k | |
| Independent Director | 8.8yrs | US$541.83k | 3.61% $ 397.0m | |
| Lead Independent Director | 2.8yrs | US$987.80k | 0.041% $ 4.5m | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Director | 1.3yrs | US$741.91k | 0.015% $ 1.6m | |
| Member of Scientific Advisory Board | no data | データなし | データなし |
4.0yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: 2VN's board of directors are considered experienced (4 years average tenure).